Comparison
2p25 3 Microduplication Syndrome C6012304 vs 14q12 Microdeletion Syndrome C4305240
Clinical comparison between 2p25 3 Microduplication Syndrome and 14q12 Microdeletion Syndrome for differential diagnosis and treatment planning.
2p25 3 Microduplication Syndrome C6012304
A rare chromosomal condition involving extra genetic material on chromosome 2. Features vary widely based on the genes involved. Treatment focuses on managing specific symptoms.
14q12 Microdeletion Syndrome C4305240
A rare chromosomal condition where a segment of chromosome 14 is missing. It may cause developmental delays and other health concerns. Treatment is supportive and individualized.
6 comparison axes
Onset
2p25 3 Microduplication Syndrome C6012304
0-5
14q12 Microdeletion Syndrome C4305240
0-1
Onset patterns differ
Severity
2p25 3 Microduplication Syndrome C6012304
severe
14q12 Microdeletion Syndrome C4305240
moderate
Different severity levels
Chronic
2p25 3 Microduplication Syndrome C6012304
Chronic
14q12 Microdeletion Syndrome C4305240
Chronic
Differing course
Communicable
2p25 3 Microduplication Syndrome C6012304
No
14q12 Microdeletion Syndrome C4305240
No
Different transmission
Body System
2p25 3 Microduplication Syndrome C6012304
congenital
14q12 Microdeletion Syndrome C4305240
congenital
Same/different system
Category
2p25 3 Microduplication Syndrome C6012304
rare-disease
14q12 Microdeletion Syndrome C4305240
genetic
Different category
Bottom line
2p25-3-microduplication-syndrome-C6012304 and 14q12-microdeletion-syndrome-C4305240 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 2p25 3 Microduplication Syndrome C6012304 | 14q12 Microdeletion Syndrome C4305240 | Discriminating power |
|---|---|---|---|
| Developmental presentation | Variable features; developmental impact is not specifically established here. | Developmental delay is described as a possible concern. | Moderate |
| Age at recognition | Supplied onset range is 0–5 years. | Supplied onset range is 0–1 year. | Moderate |
| Overall severity label | Source severity is severe, but individual course varies. | Source severity is moderate, without a fixed symptom pattern. | Low |
When to favor each condition
Choose 2p25 3 Microduplication Syndrome C6012304 when
Chromosomal microarray shows extra material at 2p25.3
The duplication itself distinguishes this condition from a 14q12 deletion.
High
Phenotype is highly variable without a defining feature
The supplied description emphasizes gene-dependent variability.
Moderate
Clinical concern arises anywhere from birth through early childhood
The supplied onset range extends to age 5.
Low
Choose 14q12 Microdeletion Syndrome C4305240 when
Testing shows a missing segment at 14q12
A deletion at this locus is the defining distinction.
High
Early developmental delay prompts genetic evaluation
Developmental delay is specifically mentioned for this condition.
Moderate
Concern is recognized in infancy
The supplied onset range is 0–1 year.
Low
How key tests differ
| Test | 2p25 3 Microduplication Syndrome C6012304 | 14q12 Microdeletion Syndrome C4305240 | Interpretation |
|---|---|---|---|
| Chromosomal microarray | Extra genetic material involving 2p25.3. | Missing genetic material involving 14q12. | The copy-number change and locus distinguish the conditions; clinical correlation is required. |
| Gene-content review | Interpretation depends on duplicated genes, which are not specified here. | Interpretation depends on deleted genes, which are not specified here. | Do not infer exact features from the locus name alone. |
| Developmental assessment | No specific developmental profile is established by the source. | May identify developmental delay, but severity is individualized. | Assessment supports care planning and does not replace genetic confirmation. |
Prognosis comparison
2p25 3 Microduplication Syndrome C6012304
- Outcome
- Long-term outcome is not established; the source labels severity as severe but features vary.
- Factors
- Duplicated genes, associated findings, and access to supportive care.
14q12 Microdeletion Syndrome C4305240
- Outcome
- Long-term outcome is not established; developmental delay and other concerns may occur.
- Factors
- Deleted genes, developmental profile, and individualized supports.
Time frame: Both are described as chronic congenital conditions; no specific survival timeframe is supplied.
Prognosis should be individualized because exact complications and outcomes are not established here.
Complications comparison
| Complication | Presentation |
|---|---|
| Developmental difficulty | Possible but not specifically characterized here. Developmental delay is a stated possible concern. Neither source establishes a uniform severity or outcome. |
| Other health concerns | Features vary widely with involved genes. Other health concerns may occur but are unspecified. Organ-specific complications should not be assumed without evaluation. |
| Support needs | Symptom-focused management may be needed. Supportive, individualized care is described. Needs depend on the person’s findings rather than the label alone. |
Patient education highlights
- HighGenetic confirmation
Ask which chromosomal region and genes are involved; the test result must be interpreted by a clinician or genetics specialist.
- HighVariable presentation
People with the same broad chromosomal finding can differ. Avoid predictions based only on the syndrome name.
- MediumCare planning
Care is supportive and individualized. Developmental, medical, and family needs should be reassessed over time.